Skip to main content
Equibles

Walleye Trading LLC

Position in VTRS — Viatris Inc

CIK 1388391 NEW YORK, NY
Back to VTRS Full portfolio

Position in VTRS

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$685,713
+$685,713 QoQ
Shares Held
50,756
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Mar 31, 2026
CallValue
$1,092,959
CallShares
80,900
PutValue
$1,137,542
PutShares
84,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Walleye Trading LLC holds $96,751,076 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 672,924 $79,546,346
2 TEVA
Teva Pharmaceutical Industries Ltd
 499,536 $15,046,024
3 VTRS
Viatris Inc
This page 		50,756 $685,713
4 ELAN
Elanco Animal Health Inc
 19,000 $454,670
5 NBIX
Neurocrine Biosciences Inc
 1,697 $223,562
6 HIMS
Hims & Hers Health, Inc.
 9,046 $187,794
7 PRGO
PERRIGO Co plc
 14,969 $160,767
8 LQDA
Liquidia Corp
 4,049 $152,809

All Filings in VTRS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,137,542 84,200
2026-03-31 $685,713 50,756
2026-03-31 $1,092,959 80,900
2025-12-31 $126,990 10,200
2025-12-31 $232,815 18,700
2025-09-30 $636,570 64,300
2025-09-30 $1,274,130 128,700
2025-06-30 $942,115 105,500
2025-06-30 $567,948 63,600
2025-03-31 $108,875 12,500
2025-03-31 $913,679 104,900
2024-12-31 $993,510 79,800
2024-12-31 $115,934 9,312
2024-12-31 $1,103,070 88,600
2024-09-30 $233,361 20,100
2024-09-30 $856,818 73,800
2024-06-30 $554,886 52,200
2024-06-30 $1,155,481 108,700
2024-03-31 $968,334 81,100
2024-03-31 $1,217,880 102,000
2023-12-31 $1,626,666 150,200
2023-12-31 $798,171 73,700
2023-12-31 $647,796 59,815
2023-09-30 $2,902,784 294,400
2023-09-30 $533,426 54,100
2023-09-30 $1,569,761 159,205
2023-06-30 $1,534,474 153,755
2023-06-30 $2,327,336 233,200
2023-06-30 $54,890 5,500
2023-03-31 $911,976 94,800
2023-03-31 $1,093,332 113,652
2023-03-31 $1,918,228 199,400
2022-12-31 $2,938,742 264,038
2022-12-31 $1,732,941 155,700
2022-12-31 $1,272,159 114,300
2022-09-30 $5,833,644 684,700
2022-09-30 $259,860 30,500
2022-06-30 $1,746,396 166,800
2022-06-30 $52,350 5,000
2022-03-31 $1,336,064 122,800
2022-03-31 $978,112 89,900
2021-12-31 $877,853 64,882
2021-12-31 $576,378 42,600
2021-12-31 $2,596,407 191,900
2021-09-30 $8,644,900 638,000
2021-09-30 $1,455,676 107,430
2021-09-30 $7,295,320 538,400
2021-06-30 $472,098 33,037
2021-06-30 $2,769,402 193,800
2021-06-30 $2,862,287 200,300

Report a Problem

Category
Description
Email (optional, for follow-up)